Abstract

Lipid disorders are now recognised as a diverse group of diseases that together represent one of the foremost risk factors for cardiovascular disease in general. Frequently present in association with other chronic illnesses such as hypertension, diabetes, and obesity, lipid disorders are a key therapeutic target for clinicians. This book examines the causes and consequences of lipid disorders, and the treatments available. Special chapters are dedicated to the associations between lipid disorders and other conditions, for example cerebrovascular disease and heart failure, as well as the wider applications for lipid-lowering agents in the management of co-morbidities. The book concludes with a review of novel lipid-modifying agents, emerging diagnostic technologies such as intravascular ultrasound, and the use of biomarkers as risk predictors.